Medical News

RSS

Association for Nutrition to be launched at The Royal Society in London

The launch of Association for Nutrition will take place today at The Royal Society in London. AfN is the professional body for the regulation and registration of nutritionists, embracing those involved in public health, care, food, exercise, policy and those who work with animals. One of the Association's responsibilities is running the UK Voluntary Register of Nutritionists.

24 Jun 2010

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).

24 Jun 2010

Amorfix Life Sciences, QED Bioscience sign agreement to develop monoclonal antibodies

Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.

24 Jun 2010

UNC team provides first example of successful radiomitigation in mammals

While radiation has therapeutic uses, too much radiation is damaging to cells. The most important acute side effect of radiation poisoning is damage to the bone marrow. The bone marrow produces all the normal blood cells, and therefore a high dose of radiation can lead to low blood counts of red cells, platelets and white blood cells.

24 Jun 2010

AVIS donates health research project focuses on cancer biomarkers

The greatest research project on cancer biomarkers is to start in the next months. The new scientific research will open new frontiers in the field of prevention of two most relevant cancer: prostate cancer and ovarian cancer. The research project, which also includes an important prevention programme, is named "AVIS donates health" (AVIS is the Italian most important blood donors association) and is supported by Fondazione Abo - Application of biotechnologies in Oncology, Avis, Lilt (Italiana League for the fight against cancer) and by the three scientific societies of gynecologists and urologists.

24 Jun 2010

MHQP survey assesses patients' experiences with primary care since health reform law implementation

A report released today by Massachusetts Health Quality Partners provides the first comprehensive assessment of how patients rate their experiences with primary care since the state's groundbreaking health reform law was implemented.

24 Jun 2010

People with certain chitinase gene variants at increased risk of severe asthma attacks

Exposure to high levels of fungus may increase the risk of severe asthma attacks among people with certain chitinase gene variants, according to a study from Harvard Medical School, Harvard Pilgrim Health Care Institute and Brigham and Women's Hospital.

24 Jun 2010

New book provides comprehensive review of the functions of p53 family

The p53 tumor suppressor gene, the "guardian of the genome," protects cells against genotoxic stress but is mutated in many cancers. It encodes one of a family of proteins that regulate cell proliferation, differentiation, senescence, and cell death. Mutations in p53 allow cells to escape normal growth controls and thereby contribute to tumor malignancy.

24 Jun 2010

Personalized medicine holds promise for the future of healthcare

With the accelerating pace of scientific discovery in life sciences, coupled with our ability to process and analyze enormous amounts of genetic information, the field of personalized medicine holds great promise for the future of healthcare.

24 Jun 2010

USPTO confirms validity of DUSA's key Levulan PDT patent

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office (USPTO) has completed its re-examination of US Patent No. 5,079,262, "Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid."

24 Jun 2010

Secretary of Labor issues statement on mental health and substance abuse benefits, services

We are very pleased that the court ruled in favor of the U.S. Departments of Labor, Treasury, and Health and Human Services, thereby allowing us to continue a regulatory process designed to benefit vulnerable members of our society. It will make mental health benefits more affordable by putting the cost on par with other health benefits.

24 Jun 2010

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Give up smoking, do not drink more than three cups of coffee per day, do not take any kind of drug, or if you do, take it as long as possible before feeding your baby. These are some of the recommendations contained in a study produced by Spanish researchers on methods for detecting medicines and drugs in breast milk. The study shows that the risk from substances such as alcohol is still not well understood.

24 Jun 2010

Physician-in-chief at Texas Children's Hospital honored with Jacqueline Kennedy Onassis Award

Last night at the 38th annual Jefferson Awards, Mark W. Kline, M.D., physician-in-chief at Texas Children's Hospital in Houston and chair of pediatrics at Baylor College of Medicine, was honored with the Jacqueline Kennedy Onassis Award for "Outstanding Community Service Benefiting Local Communities" for his dedication to treating children affected by HIV/AIDS around the world

24 Jun 2010

Study: Traditional methods for assessing patients after cardiac arrest may underestimate chances for survival

Traditional methods for assessing patients after cardiac arrest may be underestimating their chances for survival and good outcomes, according to a new study by University of Pittsburgh School of Medicine researchers now available online in the journal Resuscitation.

24 Jun 2010

Majority of North Carolinians support increasing sales tax on cigarettes

Raising taxes typically is not a popular idea, but the option of increasing cigarette sales tax has been gaining momentum in North Carolina for the past several years. Statewide polls since 2004 have shown a majority of North Carolinians support increasing the sales tax on cigarettes as a means of generating state revenue, especially when the funds are used to support public health programs and to decrease teen smoking rates.

24 Jun 2010

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

The licensing and distribution agreement allows ABL to directly host COMET (COntext-based Modeling for Expeditious Typing) subtyping tool developed at CRP-Santé within the TherapyEdge servers; it will mainly interact with the ViroScore Suite system to characterize HIV-1 virus subtypes.

24 Jun 2010

FDA grants t2cure orphan drug designation for t2c001 in Buerger's Disease

t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.

24 Jun 2010

Medica, HealthInsight partner to deliver value-based benefit program to commercial customers

Today, Medica, a leading health care insurance provider headquartered in Minneapolis, and HealthInsight, provider of the leading value-based healthcare incentive platform, announced that they have partnered to deliver a next generation value-based benefit program to Medica's commercial customers.

24 Jun 2010

Hoag Hospital launches IORT program for breast cancer treatment

Hoag Hospital announced the launch of its Intraoperative Radiation Therapy program as part of its progressive, comprehensive approach to breast cancer treatment. IORT is a radiation therapy technique in which a concentrated dose of radiation is delivered to a cancerous tumor site during surgery after the tumor is removed. Hoag Hospital is the first in Orange County to offer IORT brachytherapy for breast cancer as a component of a definitive treatment approach.

24 Jun 2010

AVEO receives EMA orphan medicinal product designation for tivozanib

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).

24 Jun 2010

Medical News

Association for Nutrition to be launched at The Royal Society in London

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Amorfix Life Sciences, QED Bioscience sign agreement to develop monoclonal antibodies

UNC team provides first example of successful radiomitigation in mammals

AVIS donates health research project focuses on cancer biomarkers

MHQP survey assesses patients' experiences with primary care since health reform law implementation

People with certain chitinase gene variants at increased risk of severe asthma attacks

New book provides comprehensive review of the functions of p53 family

Personalized medicine holds promise for the future of healthcare

USPTO confirms validity of DUSA's key Levulan PDT patent

Secretary of Labor issues statement on mental health and substance abuse benefits, services

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Physician-in-chief at Texas Children's Hospital honored with Jacqueline Kennedy Onassis Award

Study: Traditional methods for assessing patients after cardiac arrest may underestimate chances for survival

Majority of North Carolinians support increasing sales tax on cigarettes

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

FDA grants t2cure orphan drug designation for t2c001 in Buerger's Disease

Medica, HealthInsight partner to deliver value-based benefit program to commercial customers

Hoag Hospital launches IORT program for breast cancer treatment

AVEO receives EMA orphan medicinal product designation for tivozanib

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News